[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-371091-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-371091-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","germline-variant-spectrum-of-hereditary-cancer-susceptibility-genes-in-a-chinese-cohort","Germline variant spectrum of hereditary cancer susceptibility genes in a Chinese cohort","","Study of germline pathogenic variants in hereditary cancer susceptibility genes within a Chinese cohort undergoing routine health examinations. Targeted sequencing of 21 cancer predisposition genes was performed in 10,456 cancer-free adults, identifying pathogenic/likely pathogenic germline variants in 1.57% of participants. BRCA2, MUTYH, and ATM accounted for 58.5% of pathogenic variants, with eight novel pathogenic variants validated across multiple genes. Non-Han ethnic groups showed substantially higher carrier rates, while genetic counseling engagement remained low despite reported family cancer history.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/germline-variant-spectrum-of-hereditary-cancer-susceptibility-genes-in-a-chinese-cohort/371091/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/germline-variant-spectrum-of-hereditary-cancer-susceptibility-genes-in-a-chinese-cohort/371091.png","ImageObject",300,407,{"name":42,"@type":43},"hdkawk","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-28","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",14,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What was the main aim of the study?","Question",{"text":63,"@type":64},"To investigate the germline pathogenic variant spectrum of 21 cancer susceptibility genes in a Chinese cohort undergoing routine health examinations.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were pathogenic or likely pathogenic variants identified and what was the key finding?",{"text":68,"@type":64},"Targeted sequencing in 10,456 cancer-free adults identified pathogenic/likely pathogenic germline variants in 1.57% (164/10,456) of participants.",{"name":70,"@type":61,"acceptedAnswer":71},"Which genes accounted for most pathogenic variants, and what novel findings were reported?",{"text":72,"@type":64},"BRCA2, MUTYH, and ATM accounted for 58.5% of pathogenic variants. The study validated eight novel pathogenic variants across ATM, BRCA1, BRCA2, CHEK2, MUTYH, and PALB2.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},371091,1790212429,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":33,"preview_urls":147},3985747859855,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Xiong et al. Human Genomics (2026) 20:4 Human Genomics  \n[https://doi.org/10.1186/s40246-025-00873-z](https://doi.org/10.1186/s40246-025-00873-z)  \nRESEARCH Open Access  \nGermline variant spectrum of hereditary cancer susceptibility genes in a Chinese cohort  \nChanyu Xiong 1†, Xiao Wang 1,2†, Juanjuan Ji 1, Tianshu Yu 1, Yun Zhang 1,2, Zhilin Jiang 1, Jinbo Liu2, Junyu Zhang3, Yin Lin 1,2, Bo Gong 1,2 and Yu Zhou 1,2*  \nAbstract  \nBaground Hereditary cancers, caused by germline pathogenic variants in cancer susceptibility genes, account for  \n5% 10% of malignancies globally. However, their prevalence and genetic spectrum in the Chinese population remain poorly characterized. This study aimed to investigate germline pathogenic variants in 21 cancer susceptibility genes within a Chinese cohort undergoing routine health examinations.  \nResults Targeted sequencing of 21 cancer predisposition genes in 10,456 cancer-free Chinese adults (mean age 44.0 ± 10.1 years; male: 60 . 52%, n = 6328; female: 39 .48%, n = 4128) identified pathogenic/likely pathogenic germline variants in 1. 57%(164/10,456) of participants. BRCA2 (38 variants), MUTYH (29 variants), and ATM (28 variants) accounted for 58. 5% of all pathogenic variants. Eight novel pathogenic variants were validated in ATM, BRCA1, BRCA2, CHEK2, MUTYH, and PALB2 . Non-Han ethnic groups showed 4. 56-fold higher carrier rates than Han Chinese (5 . 70% vs 1. 25%; χ2 = 89 . 77, p \u003C 0. 001) . Only 6 . 1% of variant carriers pursued genetic counseling despite 49 . 39% reporting family cancer history.  \nConclusions This study reveals clinically significant germline cancer predisposition in 1. 57% of asymptomatic Chinese adults, with substantial ethnic disparities. Crucially, we identified eight novel pathogenic variants across six cancer susceptibility genes, all unreported in gnomAD/ClinVar and computationally predicted as deleterious. The 93. 9% non-engagement in genetic counseling highlights the imperative for evidence-based interventions; including provider education initiatives to advance precision prevention.  \nHighlights  \n• First large-scale analysis of pathogenic germline variants in 21 hereditary cancer susceptibility genes among  \n10,456 cancer-free Chinese individuals, providing population-specific variant spectra distinct from Western cohorts.  \n†Chanyu Xiong and Xiao Wang have contributed equally to this work.  \n*Correspondence: Yu Zhou [zhouyu422@yahoo.com](zhouyu422@yahoo.com)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/l](vecommons.org/l)icenses/by-nc-nd/4.0/.  \nXiong et al. Human Genomics (2026) 20:4 Page 2 of 11  \n• Clinically significant carrier frequency of 1. 57%, with BRCA2, MUTYH, and ATM constituting 58. 5% of pathogenic variants.  \n• Discovery of 8 novel pathogenic variants in ATM, BRCA1, BRCA2, CHEK2, MUTYH, and PALB2 genes, unreported in gnomAD/ClinVar, expanding Chinese hereditary cancer mutation spectrum.  \n• ","cbCaiqZiR6bAWSSe","https://ap.wps.com/l/cbCaiqZiR6bAWSSe","pdf",2548882,11,"English","# Abstract\n# Results\n# Conclusions\n# Highlights\n# Keywords\n# Introduction","[{\"question\":\"What was the main aim of the study?\",\"answer\":\"To investigate the germline pathogenic variant spectrum of 21 cancer susceptibility genes in a Chinese cohort undergoing routine health examinations.\"},{\"question\":\"How were pathogenic or likely pathogenic variants identified and what was the key finding?\",\"answer\":\"Targeted sequencing in 10,456 cancer-free adults identified pathogenic/likely pathogenic germline variants in 1.57% (164/10,456) of participants.\"},{\"question\":\"Which genes accounted for most pathogenic variants, and what novel findings were reported?\",\"answer\":\"BRCA2, MUTYH, and ATM accounted for 58.5% of pathogenic variants. The study validated eight novel pathogenic variants across ATM, BRCA1, BRCA2, CHEK2, MUTYH, and PALB2.\"}]","Germline variant spectrum of hereditary cancer susceptibility genes in a Chinese cohort | PDF",1790191221,28,[148,152,156,160],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1da39d23e850387ced8f84f833280b76.webp",983,1310,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ccde5d09a2e84adf7a48c445059480c1.webp",982,1309,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c5cb33e9fb515b6be3b253dd335df276.webp",981,1308,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7b2ff0fb975cdfee97d7b4886372c0e2.webp",980,1306]